Live Patient Cases to be Supported by BioSig’s PURE EP System During EPLive 2020

BioSig Technologies (NASDAQ: BSGM) is a medical technology company which designs and commercializes an innovative signal processing platform. Bio Sig’s signal processing platform is aimed to uncover the full range of ECG and intra-cardiac signals and to improve signal fidelity.

BioSig Technologies has recently announced that during EPLive 2020, the fifth international symposium on complex arrhythmias, its first product, the PURE EP system, would be featured in several live cases broadcast.

This symposium is a two-day educational meeting. Participants of the EPLive are mostly practicing clinical cardiac electrophysiologists, electrophysiology fellows, and general cardiologists interested in treating complex cardiac arrhythmias.

From the new, state-of-the-art Electrophysiology Center at St. David’s Medical Center in Austin, TX, will be broadcasted a total of 21 live and 13 recorded cases. There will be an also an expert commentary. This will serve as the primary teaching tool.

BioSig Technologies’ PURE EP System will be present in several patient cases. These cases will be conducted live by Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., Executive Medical Director of TCAI and EPLive course director, and Joseph Gallinghouse, M.D.

BioSig Technologies Chairman and CEO, Kenneth Londoner commented recently that they are thrilled to be included in this very unique physician education event. BioSig Technologies appreciates all the effort that went into making EPLive a reality amidst the global pandemic.

BioSig Technologies Chairman and CEO also pointed out that they are really for the outstanding support that Dr. Natale and his colleagues at TCAI are providing to BioSig Technologies team and for their dedication to improving patient outcomes through the introduction of sophisticated educational tools and techniques for the benefit of the global physician audience.

BioSig’s PURE EP System was firstly installed at Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center. So far, over 350 cases have been performed with the BioSig’s PURE EP System by 25 electrophysiologists across several clinical sites.